Insider: Eisele Jeffrey Chief Development Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 55,312 | 0 | 55,312 |
| Value | $1,237,329.44 | $0.00 | $1,237,329.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/29/2025 | DDS | 278 | Direct | COM | $29.52 | $8,207.56 | 55,312 |
| 01/22/2025 | DDS | 1,291 | Direct | COM | $30.43 | $39,279.32 | 55,590 |
| 01/13/2025 | DDS | 264 | Direct | COM | $28.70 | $7,577.35 | 56,881 |
| 12/23/2024 | DDS | 63 | Direct | COM | $33.09 | $2,084.67 | 57,145 |
| 01/30/2024 | DDS | 971 | Direct | COM | $65.53 | $63,629.63 | 57,208 |
| 01/29/2024 | DDS | 279 | Direct | COM | $64.14 | $17,894.56 | 58,179 |
| 01/23/2024 | DDS | 7,378 | Direct | COM | $63.69 | $469,904.82 | 58,458 |
| 01/22/2024 | DDS | 1,607 | Direct | COM | $65.00 | $104,448.57 | 65,836 |
| 01/17/2024 | DDS | 5,207 | Direct | COM | $65.58 | $341,475.06 | 67,443 |
| 01/16/2024 | DDS | 438 | Direct | COM | $66.81 | $29,262.17 | 72,650 |
| 12/27/2023 | DDS | 235 | Direct | COM | $60.23 | $14,154.05 | 53,580 |
| 12/26/2023 | DDS | 68 | Direct | COM | $57.86 | $3,934.54 | 53,815 |
| 02/23/2023 | DDS | 1,646 | Direct | COM | $68.76 | $113,178.96 | 53,883 |
| 01/30/2023 | DDS | 883 | Direct | COM | $52.76 | $46,587.08 | 46,468 |
| 01/23/2023 | DDS | 4,479 | Direct | COM | $51.58 | $231,026.82 | 47,718 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research